Biotechnology

Click here to view our Biotechnology professionals

Our biotechnology practice includes such services as patent procurement, interference and opposition practice, litigation - both plaintiff and defense positions, licensing, technology transfer, patent validity and infringement opinions, and other areas of client counseling. Spearheaded by attorneys, agents, and law clerks with advanced degrees in such areas as biochemistry, molecular biology, immunology, and plant sciences, our biotechnology practice has the combination of technical expertise and legal experience that enables us to represent our clients in the most sophisticated arenas.

We work extensively in cutting-edge sub-specialties, such as the production and use of antisense oligonucleotides, ribozymes, recombinant genes and proteins, monoclonal antibodies, gene-gun applications, and pharmaceutical products for disease treatment and diagnosis, apparatuses and techniques for isolating, labeling, and detecting molecules of biological importance. Our focus on the burgeoning field of nanotechnology is one of the most comprehensive in the legal profession. We understand the far-reaching implications of nanotechnology and its potential to transform technology as we now know it.

Our substantial experience extends worldwide and includes strategic development and the protection of intellectual property for Fortune 500 multinational corporations as well as start-up biotechnology companies.

P: 312.935.2369
F: 312.913.0002
P: 312.913.2140
F: 312.913.0002
P: 312.913.3357
F: 312.913.0002
P: 312.913.2130
F: 312.913.0002
P: 312.913.2146
F: 312.913.0002
P: 312.913.3330
F: 312.913.0002
P: 312.913.3345
F: 312.913.0002
P: 312.913.2109
F: 312.913.0002
P: 312.913.2121
F: 312.913.0002
P: 312.913.2117
F: 312.913.0002
P: 312.913.3369
F: 312.913.0002
P: 312.913.3315
F: 312.913.0002
P: 312.913.3333
F: 312.913.0002
P: 312.913.2135
F: 312.913.0002
P: 312.913.3366
F: 312.913.0002
P: 312.913.2116
F: 312.913.0002
P: 312.913.2106
F: 312.913.0002
P: 312.935.2371
F: 312.913.0002
P: 312.935.2372
F: 312.913.0002
P: 312.913.3311
F: 312.913.0002
P: 312.913.3393
F: 312.913.0002
P: 312.913.3346
F: 312.913.0002
P: 312.913.3344
F: 312.913.0002
P: 312.913.2126
F: 312.913.0002
P: 312.913.2145
F: 312.913.0002
P: 312.913.3335
F: 312.913.0002
P: 312.913.3349
F: 312.913.0002
P: 312.913.2133
F: 312.913.0002
P: 312.913.2136
F: 312.913.0002
P: 312.935.2379
F: 312.913.0002
P: 312.913.3368
F: 312.913.0002
P: 312.913.3301
F: 312.913.0002
P: 312.913.2114
F: 312.913.0002
P: 312.913.2132
F: 312.913.0002

Upcoming Events

September 11-12, 2014
Five MBHB Partners Are Featured Presenters at this PLI-Sponsored Seminar

Past Event

July 9, 2014
MBHB Partners Grantland Drutchas and Donald Zuhn, Ph.D. Are the Featured Co-Presenters
June 25, 2014
MBHB Partner Dr. Donald Zuhn is the Featured Moderator at this BIO 2014 Session
June 12, 2014
MBHB Partner Dr. Andrew Williams is the Featured Moderator at this ABA Sponsored Roundtable Event
June 10, 2014
MBHB Partner Paul Tully Is a Featured Presenter at this ACI-Sponsored Event
June 10, 2014

Publications

June 19, 2014 (snippets Alert)
MBHB snippets Alert - June 19, 2014

In the U.S. Supreme Court’s decision today in Alice Corp. v. CLS Bank International, the Court affirmed the invalidity of Alice’s patents for computer-implemented methods of reducing settlement risk. This case reached the high court after a severely split Federal Circuit could not agree whether language of the claims met the patent-eligibility requirements of 35 U.S.C. § 101. At the heart of this case was the Federal Circuit’s confusion over the impact of the Court’s 2012 decision, Mayo Collaborative Services v. Prometheus Laboratories, Inc.

June 2, 2014 (snippets Alert)
MBHB snippets Alert - June 2, 2014

In the U.S. Supreme Court’s decision today in Limelight Networks, Inc. v. Akamai Technologies, Inc., the Supreme Court reversed the Federal Circuit's en banc holding that a defendant need not perform all of the steps of a claim to infringe where it performs some and induces third parties to perform the rest.
June 2, 2014 (snippets Alert)
MBHB snippets Alert - June 2, 2014

In today’s decision, the U.S. Supreme Court in Nautilus, Inc. v. Biosig Instruments, Inc. clarified the scope of definiteness required to fulfill the requirement that the patent claims particularly point out and distinctly claim the subject matter which the applicant regards as the invention. In Nautilus, the U.S. Supreme Court unanimously rejected the “insolubly ambiguous” standard previously set out by the Federal Circuit.
May 19, 2014 (snippets Alert)

MBHB snippets Alert - May 19, 2014

Today in Petrella v. Metro-Goldwyn-Mayer, Inc. (case number 12-1315), the U.S. Supreme Court ruled that the doctrine of laches could not be invoked to bar a copyright claim that was brought within the statutorily allowed three-year window from the particular act of infringement. In Petrella, the Court reversed the decision of the Ninth Circuit Court of Appeals, which had affirmed the district court’s summary dismissal of the suit based on laches. Resolving a circuit split at the appellate level, the Supreme Court held that the lower courts erred in “failing to recognize that the copyright statute of limitations, §507(b), itself takes account of delay.” Petrella, slip op. at 11. The opinion emphasized that the Supreme Court has “never applied laches to bar in their entirety claims for discrete wrongs occurring within a federally prescribed limitations period.” Id. at 14-15. Rather, the Court stated that laches is a “gap-filling, not legislation-overriding,” measure that is appropriate only when there is not an explicit statute of limitations. Id at 14.

Spring 2014 (snippets)

Trademark protection is very important in the fashion industry. The ability to protect certain logos and design features may determine the success of a fashion designer’s business. Thus, it is crucial to understand how to protect your fashion trademarks and trade dress.

Spring 2014 (snippets)
Part I of this article addressed basic concepts of data privacy as set out in the policies of numerous regional and multilateral organizations, including the Organisation for Economic Co-operation and Development (“OECD”), Asia-Pacific Economic Cooperation (“APEC”), and the Association of Southeast Asian Nations (“ASEAN”). In Part II, we discuss the specific policies of several Asia-Pacific nations and provide a general framework for addressing data privacy issues throughout the litigation process.
Close
Generate a PDF of your page(s)
Clear
Close
Remove
Page has been queued
An error has occurred
Add
Added to queue
View
Confirm Delete All Message
No Items in Packet Message
To add a page, select Add. To view the package, select View.
false
http://www.mbhb.com/services/xpqServiceDetail.aspx?xpST=ServiceDetail&service=296&pdf=yes
a[href='javascript:packetBuilderSingleClick(document.title);']